Positions

Overview

  • Marshall M. Urist, M.D. is the Vice-Chairman of Education for the Department of Surgery at the UAB. He is a native Californian who joined the UAB faculty in 1981 after completing his medical education and surgical training at the University of Chicago, the Johns Hopkins Hospital and the University of California at Los Angeles. He headed the Section of Surgical Oncology from 1985 to 2007. He was the director of the general surgery residency program from 1991 to 2012. His major activities center around surgical education, clinical trials and patient care. He served as Director of the American Board of Surgery and was Chairman of the Surgical Oncology Advisory Council of the ABS. He has been active in raising educational standards in surgical oncology as chairman of the Training Committee of the Society of Surgical Oncology and as an officer of the Commission on Cancer of the American College of Surgeons. He is the author or co-author of over 100 journal publications and 40 textbook chapters. Over the past 34 years, he has contributed to the organization, oversight and accessions for cancer clinical trials at the regional, national and international levels.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2018 Treatment patterns for ductal carcinoma in situ with close or positive mastectomy margins 2018
    2016 NCCN Guidelines Insights: Melanoma, Version 3.2016. 2016
    2016 NCCN Guidelines® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines 2016
    2016 Basal cell skin cancer, version 1.2016: Clinical practice guidelines in oncology 2016
    2016 Final Results of the Sunbelt Melanoma trial: A multi-institutional prospective randomized phase III study evaluating the role of adjuvant high-dose interferon alfa-2b and completion lymph node dissection for patients staged by sentinel lymph node biopsy 2016
    2016 Melanoma, version 2.2016 clinical practice guidelines in oncology 2016
    2014 Dermatofibrosarcoma protuberans, version 1.2014 2014
    2014 Melanoma, version 4.2014. 2014
    2014 Melanoma, version 4.2014: Featured updates to the NCCN guidelines 2014
    2014 Merkel cell carcinoma, version 1.2014. 2014
    2014 What is a clear margin in breast conserving cancer surgery? 2014
    2013 Diversity of stage III melanoma in the era of sentinel lymph node biopsy 2013
    2013 Melanoma, version 2.2013: Featured updates to the NCCN guidelines 2013
    2012 A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: Comparison with the American joint committee on cancer model 2012
    2012 Dermatofibrosarcoma protuberans 2012
    2012 Melanoma 2012
    2011 Descriptive operative reports: Teaching, learning, and milestones to safe surgery 2011
    2011 Long-term follow-up of dose-dense neoadjuvant chemotherapy in patients with stage II/III breast cancer. 2011
    2011 Discussion 2011
    2011 The University of Alabama at Birmingham: School of Medicine and Department of Surgery 2011
    2010 Surveillance after surgical treatment of melanoma: Futility of routine chest radiography 2010
    2010 Pilot trial of preoperative (Neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor-or progesterone receptor-positive breast cancer 2010
    2010 Prognostic information from sentinel lymph node biopsy in patients with thick melanoma 2010
    2010 Second primary melanomas: Incidence and outcome 2010
    2010 Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? 2010
    2010 Factors associated with false-negative sentinel lymph node biopsy in melanoma patients 2010
    2010 Basal cell and squamous cell skin cancers 2010
    2010 Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma 2010
    2009 Specimen radiographs assist in identifying and assessing resection margins of occult breast carcinomas 2009
    2009 Discussion 2009
    2009 Discussion 2009
    2009 Melanoma 2009
    2009 Merkel cell carcinoma 2009
    2008 Board certification in surgical oncology: ABS certification is not the answer for surgical oncology 2008
    2008 Effect of multiple-nodal basin drainage on cutaneous melanoma 2008
    2007 Factors Associated With Improved Survival Among Young Adult Melanoma Patients Despite a Greater Incidence of Sentinel Lymph Node Metastasis 2007
    2007 Thyroid carcinoma 2007
    2007 Basal cell and squamous cell skin cancers 2007
    2007 Dermatofibrosarcoma protuberans 2007
    2006 Melanoma. 2006
    2006 Melanoma: Clinical practice guidelines in oncology™ 2006
    2006 Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma 2006
    2006 Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma 2006
    2006 Safety and effectiveness of dose dense neoadjuvant chemotherapy in patients with stage II/III breast cancer. 2006
    2006 Gender-related differences in outcome for melanoma patients 2006
    2005 Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer 2005
    2005 E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7 2005
    2004 Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: An interim analysis of a prospective multi-institutional cohort study 2004
    2004 Treatment options for merkel cell carcinoma 2004
    2003 Expression of p53 and proliferation index as prognostic factors in gastrointestinal sarcomas 2003
    2003 Laparoscopic adrenalectomy and splenectomy are safe and reduce hospital stay and charges 2003
    2003 Results of long-term follow-up for transanal excision for rectal cancer 2003
    2003 Axillary Lymph Node Status, but Not Tumor Size, Predicts Locoregional Recurrence and Overall Survival after Mastectomy for Breast Cancer 2003
    2003 Local recurrence after breast conserving therapy for invasive breast cancer: Analysis of prognostic factors 2003
    2003 Melanoma and sentinel nodes. 2003
    2002 Occult breast carcinoma presenting with axillary lymph node metastases 2002
    2002 Factors associated with local recurrence after skin-sparing mastectomy and immediate breast reconstruction for invasive breast cancer 2002
    2001 Sentinel node biopsy for cutaneous melanoma in the head and neck 2001
    2001 Sentinel node biopsy for cutaneous melanoma in the head and neck. 2001
    2001 Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system 2001
    2001 Role of matrix metalloproteinases in colorectal carcinogenesis 2001
    2001 Molecular biomarkers for breast cancer prognosis: Coexpression of c-erbB-2 and p53 2001
    2001 Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. 2001
    2001 Reducing the cost of diagnosis of breast carcinoma: Impact of ultrasound and imaging-guided biopsies on a clinical breast practice 2001
    2001 Colorectal hepatic metastases: Resection, local ablation, and hepatic artery infusion pump are associated with prolonged survival 2001
    2001 Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas 2001
    2001 Multimodality Treatment for Patients with Hepatocellular Carcinoma: Analysis of Prognostic Factors in a Single Western Institution Series 2001
    2001 Multimodality treatment of merkel cell carcinoma: Case series and literature review of 1024 cases 2001
    2000 Extent of surgery for intermediate-risk well-differentiated thyroid cancer 2000
    2000 Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm) 2000
    2000 Primary gastrointestinal sarcomas 2000
    1999 Merkel cell carcinoma occurring in renal transplant patients 1999
    1999 Merkel cell carcinoma occurring in renal transplant patients. 1999
    1999 Melanoma 1999
    1999 T1 and t2 squamous cell carcinoma of the oral tongue: Prognostic factors and the role of elective lymph node dissection 1999
    1998 NGGN Melanoma Practice Guidelines 1998
    1998 Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: The final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial 1998
    1998 Factors affecting survival following local, regional, or distant recurrence from localized melanoma 1998
    1998 Factors affecting survival following local, regional, or distant recurrence from localized melanoma. 1998
    1998 Clinical outcomes of localized melanoma of the foot: A case-control study 1998
    1997 Increased survival of patients treated with a vaccinia melanoma oncolysate vaccine: Second interim analysis of data from a phase III, multi- institutional trial 1997
    1997 Classification of localized melanoma by the exponential survival trees method 1997
    1997 Classification of localized melanoma by the exponential survival trees method. 1997
    1996 Management of patients with intermediate-thickness melanoma 1996
    1996 Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trial 1996
    1996 Surgical management of primary cutaneous melanoma 1996
    1995 A phase III randomized, doúble‐blind, multiinstitutional trial of vaccinia melanoma oncolysate‐active specific immunotherapy for patients with stage II melanoma 1995
    1995 Melanoma recurrence surveillance patient or physician based? 1995
    1995 Needle-localization biopsy of the breast: Impact of a selective core needle biopsy program on yield 1995
    1995 Oncologic Aspects of Autogenous Breast Reconstruction 1995
    1995 Prognostic factors in minor salivary gland cancer 1995
    1995 Workup of a patient with a mass in the neck. 1995
    1994 Insurance coverage of patients with breast cancer in the 1991 Commission on Cancer patient care evaluation study 1994
    1994 The National Cancer Data Base. Report on melanoma. 1994
    1994 1991 National survey of carcinoma of the breast by the commission on cancer 1994
    1994 Patterns of care for younger women with breast cancer. 1994
    1994 The national cancer data base. Report on melanoma 1994
    1993 Clinical, radiographic, and pathologic correlation of atypical hyperplasia, ductal carcinoma in situ, and ductal carcinoma in situ with micro-invasion 1993
    1993 Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancer 1993
    1992 Predicting survival and recurrence in localized melanoma: A multivariate approach 1992
    1992 Paragangliomas of the Neck 1992
    1992 Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer 1992
    1991 Lack of effect of pregnancy on outcome of melanoma 1991
    1991 Metastatic malignant fibrohistiocytic tumors masquerading as pleura-based cyst-like lesions. 1991
    1990 Histopathological prognostic factors of certain primary oral cavity cancers. 1990
    1990 Florid papillomatosis of the nipple: immunohistochemical and flow cytometric analysis of two cases. 1990
    1989 Conventional tram flap versus free microsurgical tram flap for immediate breast reconstruction 1989
    1989 Conventional tram flap versus free microsurgical tram flap for immediate breast reconstruction 1989
    1988 Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically. 1988
    1988 Thin Stage I Primary Cutaneous Malignant Melanoma 1988
    1988 Clinical use of a standard kit-preparation of radiolabeled monoclonal antibody 96.5 in the diagnostic imaging of metastatic melanoma 1988
    1988 In Reply 1988
    1988 Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma 1988
    1988 Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically 1988
    1988 Resection of the liver for colorectal carcinoma metastases - A multi-institutional study of long-term survivors 1988
    1988 Simultaneous therapy with high-dose cisplatin and radiation for unresectable squamous cell cancer of the head and neck: A phase I-II study 1988
    1988 Total Pharyngeal Reconstruction Using a Pectoralis Major Myocutaneous Tunnel 1988
    1987 Is modified radical neck dissection only a staging procedure? 1987
    1987 CURRENT STATUS OF NECK DISSECTION IN THE MANAGEMENT OF SQUAMOUS CARCINOMA OF THE HEAD AND NECK 1987
    1987 Does Radical Mastectomy Still Have a Place in the Treatment of Primary Operable Breast Cancer? 1987
    1987 Is modified radical neck dissection only a staging procedure? 1987
    1987 Modified radical neck dissection. Terminology, technique, and indications 1987
    1987 Squamous cell carcinoma of the buccal mucosa: Analysis of prognostic factors 1987
    1986 Ultrasound of the breast. What are the indications? 1986
    1986 Intraarterial chemotherapy for colorectal liver metastases and hepatomas using a totally implantable drug infusion pump. 1986
    1986 Malignant salivary tumors—analysis of prognostic factors and survival 1986
    1986 Neck dissection with and without radiotherapy: Prognostic factors, patterns of recurrence, and survival 1986
    1986 Surgery as palliative treatment for distant metastases of melanoma 1986
    1986 Surgical treatment of early‐stage carcinoma of the oral tongue—would adjuvant treatment be beneficial? 1986
    1985 The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. 1985
    1985 Predicting the risk of abdominal disease in Hodgkin's lymphoma. A multifactorial analysis of staging laparotomy results in 255 patients 1985
    1985 The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma 1985
    1984 Preoperative regional chemotherapy and rapid-fraction irradiation for sarcomas of the soft tissue and bone 1984
    1984 [Intra-arterial chemotherapy using an implantable infusion pump in liver metastases of colorectal tumors and hepatomas]. 1984
    1984 Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment 1984
    1984 Intraarterial chemotherapy with implanted infusion for hepatomas and liver metastasis of colorectal tumors 1984
    1983 A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. 1983
    1983 [Completely implantable infusion pump. A new therapeutic possibility for selected patients with liver tumors]. 1983
    1983 Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients. 1983
    1983 Hepatocellular carcinoma: characteristics and current management. 1983
    1983 A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump 1983
    1983 A randomized prospective trial of radical (Halsted) mastectomy versus modified radical mastectomy in 311 breast cancer patients 1983
    1983 Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. A feasibility study in 50 patients 1983
    1983 Patient risk factors and surgical morbidity after regional lymphadenectomy in 204 melanoma patients 1983
    1977 The nature of immune complexes in human cancer sera 1977
    1977 A rational approach to the surgical management of melanoma 1977
    1977 In vitro evidence for increased cellular immunity to lung cancer antigen during Levamisole immunotherapy 1977
    1976 Capillary tube leukocyte adherence inhibition: An assay for cell‐mediated immunity in cancer patients 1976
    1976 Detection of human tumor‐associated antigens by the leukocyte migration in agarose assay 1976
    1975 Cellular immunity to tumor associated antigens in sarcoma patients and their relatives 1975
    1975 Inhibition of leukocyte migration in agarose by KC1 extracts of a human melanoma cell line grown in serum‐free medium 1975

    Education And Training

  • Doctor of Medicine, University of Chicago 1971
  • Full Name

  • Marshall Urist